STRUCTURE AND FUNCTION OF URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASES
Tóm tắt
1. The uridine diphosphate (UDP)‐glucuronosyltransferases (UGT) are a family of enzymes that catalyse the covalent addition of glucuronic acid to a wide range of lipophilic chemicals. They play a major role in the detoxification of many exogenous and endogenous compounds by generating products that are more polar and, thus, more readily excreted in bile or urine.
2. Inherited deficiencies in UGT forms are deleterious, as exemplified by the debilitating effects of hyperbilirubinaemia and neurotoxicity in subjects with mutations in the enzyme that converts bilirubin to its more pola. glucuronide.
3. The UGT protein can be conceptually divided into two domains with the amino‐terminal half of the protein demonstrating greater sequence divergence between isoforms. This region apparently determines aglycone specificity. The aglycone binding site is presumed to be a ‘loose’ fit, as many structurally diverse substrates can be bound by the same UGT isoform. The carboxyl‐terminal half, which is more conserved in sequence between different isoforms, is believed to contain a binding site for the cosubstrate UDP glucuronic acid (UDPGA).
4. Uridine diphosphat. glucuronosyltransfera.se is localized to the endoplasmic reticulum (ER) and spans the membrane with a type I topology. The putative transmembrane domain is located near the carboxyl terminus of the protein such that only a small portion of the protein resides in the cytosol. This cytosolic tail is believed to contain an ER‐targeting signal. The major portion of the protein is located in the ER lumen, including the proposed substrate‐binding domains and the catalytic site.
5. The microsomal membrane impedes the access of UDPGA to the active site, resulting in latency of UGT activity in intact ER‐derived microsomes. Active transport of UDPGA is believed to occur in hepatocytes, but the transport system has not been fully characterized. Uridine diphosphate glucuronosyltransfer‐ase activity is also highly lipid dependent and the enzyme may contain regions of membrane association in addition to the transmembrane domain.
Từ khóa
Tài liệu tham khảo
Dutton GJ., 1980, Glucuronidation of drugs and other compounds
Williams AM, 1992, Studies on the reactivity of acyl glucuronides III, Mol. Pharmacol., 43, 745
Mackenzie PI., 1995, The UDP glucuronosyltransferase multigene family, Rev. Biochem. Toxicol., 11, 29
Iyanagi T., 1986, Cloning and characterization of cDNA encoding 3‐methylcholanthrene inducible rat mRNA for UDP‐glucuronosyltransferase, J. Biol. Chem., 261, 15607, 10.1016/S0021-9258(18)66758-4
Crigler JF, 1952, Congenital familial non‐hemolytic jaundice with kernicterus, Pediatrics, 10, 169
Moghrabi N., 1993, Cosegregation of intragenic markers with a novel mutation that causes Crigler‐Najjar syndrome Type 1: Implications in carrier detection and prenatal diagnosis, Am. J. Hum. Genet., 53, 722
Ciotti M., 1996, Altered coding for a strictly conserved di‐glycine in the major bilirubin UDP‐glucurono‐syltransferase of a Crigler‐Najjar type I patient, J. Biol. Chem., 270, 3284, 10.1074/jbc.270.7.3284
Mackenzie PI, 1984, Cleavage of nascent UDP‐glucuronosyltransferase from rat liver by pancreatic microsomes, Biochem. J., 122, 1441
Mackenzie PI., 1990, Expression of chimeric cDNAs in cell culture defines a region of UDP glucuronosyltransferase involved in substrate selection, J. Biol. Chem., 265, 3432, 10.1016/S0021-9258(19)39785-6
King CD, 1997, Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuro‐nidation of opioid compounds, Drug Metab. Disp., 25, 251
Coffman BL, 1997, Human UGT2B7 catalyzes morphine glucuronidation, Drug Metab. Disp., 25, 1
Mackenzie PI., 1990, Frontiers in Biotransformation, Vol. 2. Principles, mechanisms and biological consequences of induction, 211, 10.1515/9783112563304-009
Senay C., 1997, Arginine 52 and histidine 54 located in a conserved amino‐terminal hydrophobic region (LX2‐R52‐G‐H54‐X3‐V‐L) are important amino acids for the functional and structural integrity of the human liver UDP glucuronosyltransferase UGT1*6, Mol. Pharmacol., 51, 406
Hauser SC, 1984, Subcellular distribution and regulation of hepatic bilirubin UDP‐glucuronosyltransferase, J. Biol. Chem., 259, 4527, 10.1016/S0021-9258(17)43078-X
Magdalou J., 1982, Factors modulating the catalytic activity of a pure form of UDP glucuronosyltransferase, J. Biol. Chem., 257, 13624, 10.1016/S0021-9258(18)33493-8
Fournel‐GigleuxS. OuzzineM. BattagliaE.et al.Membrane topology and organization of human UDP‐glucuronosyltransferase. In:Proceedings of the VIIIth International Workshop on Glucuronidation and the UDP‐Glucuronosyitransferases.1996.
Bock KW, 1994, Handbook of experimental pharmacology, Vol. 112. Conjugation/deconjugation reactions in drug metabolism and toxicity, 3914
Yokota H., 1992, Topological disposition of UDP glucuronosyltransferase in rat liver microsomes, J. Biochem., 112, 192, 10.1093/oxfordjournals.jbchem.a123876
Crawford JM, 1988, Hepatocyte cotransport of taurocholate and bilirubin glucuronides: Role of microtubules, Am. J. Physiol., 255, G121